The 'never-ending story' of the influence of blood specimen collection methods affecting the concentration, the zymographic profile and the usefulness of matrix metalloproteinases and their tissue inhibitors in multiple sclerosis diagnosis/prognosis: a landmark for limiting the misuse of serum samples.
作者信息
Mannello F, Tonti G A M, Canestrari F
出版信息
Mult Scler. 2007 Jun;13(5):687-90. doi: 10.1177/1352458506072492. Epub 2007 Feb 9.
PMID:17548455
Abstract
摘要
相似文献
1
The 'never-ending story' of the influence of blood specimen collection methods affecting the concentration, the zymographic profile and the usefulness of matrix metalloproteinases and their tissue inhibitors in multiple sclerosis diagnosis/prognosis: a landmark for limiting the misuse of serum samples.血液标本采集方法对多发性硬化症诊断/预后中基质金属蛋白酶及其组织抑制剂的浓度、酶谱分析以及效用的影响这一“永无止境的故事”：限制血清样本滥用的一个里程碑
Mult Scler. 2007 Jun;13(5):687-90. doi: 10.1177/1352458506072492. Epub 2007 Feb 9.
2
Matrix metalloproteinases (MMP): determination of different forms by different techniques may require different preanalytical strategies.基质金属蛋白酶（MMP）：采用不同技术测定不同形式可能需要不同的分析前策略。
Mult Scler. 2007 May;13(4):561-2. doi: 10.1177/1352458506070897. Epub 2007 Feb 9.
3
Matrix metalloproteinases (MMP): determination of different forms by different techniques may require different preanalytical strategies.基质金属蛋白酶（MMP）：采用不同技术测定不同形式可能需要不同的分析前策略。
Mult Scler. 2007 Jun;13(5):691-2. doi: 10.1177/1352458507080433.
4
Serum or plasma samples? The "Cinderella" role of blood collection procedures: preanalytical methodological issues influence the release and activity of circulating matrix metalloproteinases and their tissue inhibitors, hampering diagnostic trueness and leading to misinterpretation.血清还是血浆样本？采血程序的“灰姑娘”角色：分析前的方法学问题会影响循环基质金属蛋白酶及其组织抑制剂的释放和活性，妨碍诊断准确性并导致误解。
Arterioscler Thromb Vasc Biol. 2008 Apr;28(4):611-4. doi: 10.1161/ATVBAHA.107.159608.
5
Preanalytical biases in measurement of matrix metalloproteinases and their tissue inhibitors in peripheral blood.外周血中基质金属蛋白酶及其组织抑制剂检测中的分析前偏倚
J Rheumatol. 2007 Apr;34(4):890-2; author reply 892.
6
Consideration of preanalytical impact of blood sampling on measurement of matrix metalloproteinases and their inhibitors as precondition to evaluate their relationship to clinical data.将血液采样的分析前影响纳入对基质金属蛋白酶及其抑制剂测量的考量，以此作为评估它们与临床数据关系的前提条件。
Mult Scler. 2009 Nov;15(11):1372-3; author reply 1374-5. doi: 10.1177/1352458509106855.
7
Measurement of matrix metalloproteinases and their tissue inhibitors in serum produces doubtful results.血清中基质金属蛋白酶及其组织抑制剂的测量结果令人怀疑。
J Infect Dis. 2008 Dec 1;198(11):1722-3; author reply 1723-4. doi: 10.1086/593070.
8
Influence of blood sampling procedure on plasma concentrations of matrix metalloproteinases and their tissue inhibitors.采血程序对基质金属蛋白酶及其组织抑制剂血浆浓度的影响。
Clin Exp Pharmacol Physiol. 2008 Apr;35(4):464-9. doi: 10.1111/j.1440-1681.2008.04897.x.
9
Matrix metalloproteinases and their tissue inhibitors (TIMPs) in Plasmodium falciparum malaria: serum levels of TIMP-1 are associated with disease severity.恶性疟原虫疟疾中的基质金属蛋白酶及其组织抑制剂（TIMPs）：TIMP-1的血清水平与疾病严重程度相关。
J Infect Dis. 2008 Jun 1;197(11):1614-20. doi: 10.1086/587943.
10
Differences in both matrix metalloproteinase 9 concentration and zymographic profile between plasma and serum with clot activators are due to the presence of amorphous silica or silicate salts in blood collection devices.使用凝血激活剂时，血浆和血清中基质金属蛋白酶9浓度及酶谱的差异是由于采血装置中存在无定形二氧化硅或硅酸盐。
Anal Biochem. 2008 Mar 1;374(1):56-63. doi: 10.1016/j.ab.2007.11.020. Epub 2007 Nov 22.
引用本文的文献
1
Translating molecular medicine into clinical tools: doomed to fail by neglecting basic preanalytical principles.将分子医学转化为临床工具：因忽视基本的分析前原则而注定失败。
J Transl Med. 2009 Oct 14;7:87. doi: 10.1186/1479-5876-7-87.
Zotero 插件